Previous Close | 0.3450 |
Open | 0.3530 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.3530 - 0.3530 |
52 Week Range | 0.3305 - 0.6960 |
Volume | |
Avg. Volume | 1,062 |
Market Cap | 24.001M |
Beta (5Y Monthly) | 1.38 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0600 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
PARIS & BOSTON, April 25, 2024--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today reported its financial results for the full year 2023 and its sales for the first quarter 2024.
PARIS & BOSTON, April 24, 2024--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT) (Paris:ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced the execution of an agreement to restructure €21.3 million in outstanding debt obligations related to the Company’s finance contract with the European Investment Bank (EIB).
PARIS, April 04, 2024--Regulatory News: Mauna Kea Technologies (Paris:ALMKT):